We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Molecular Probe Lights Up Staph Infections

By LabMedica International staff writers
Posted on 17 Feb 2014
A novel chemical probe comprising a self-quenching fluorescently labeled oligonucleotide allows for the rapid, noninvasive detection of staphylococcal (staph) infections.

To more easily identify sites of staph infection investigators at the University of Iowa (Iowa City, USA) created a novel molecular probe. More...
The probe comprised a pair of deoxythymidines flanked by several 2′-O-methyl–modified nucleotides. Various chemical modifications rendered the molecule resistant to mammalian serum nucleases while leaving it susceptible to the action of staphylococcal micrococcal nuclease (MN). A fluorophore was attached to one end of the probe while a molecule that quenched the fluorescence was attached to the other. The presence of the quencher prevented emission of any fluorescent light.

The action of Staphylococcus aureus MN, an endo-exonuclease that digests single-stranded and double-stranded DNA and RNA, digested the probe and liberated the fluorophore from the suppressing effect of the quencher. As the probe was susceptible to digestion only by staph MN, the appearance of fluorescence pinpointed the site of bacterial infection.

The probe's fluorescence was activated in culture supernatants of S. aureus but not in culture supernatants of several other pathogenic bacteria. Systemic administration of this probe to mice bearing S. aureus muscle infections resulted in probe activation at the infection sites in an MN-dependent manner.

"We have come up with a new way to detect staph bacteria that takes less time than current diagnostic approaches," said senior author Dr. James McNamara, assistant professor of internal medicine at the University of Iowa. "It builds on technology that has been around a long time, but with an important twist that allows our probe to be more specific and to last longer. If the probe gets cleaved by serum nucleases, then our probe would be lit up all over the bloodstream. But since it is split only by staph nucleases, then we can pinpoint where the staph bacteria are active."

The investigators applied for US patent to protect use of the molecule in the fall of 2012, and plan to refine the probe so it can be detected deeper in the body and with catheter infections.

A paper describing the novel probe for staph infections was published in the February 2, 2014, online edition of the journal Nature Medicine.

Related Links:

University of Iowa



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Sample Transportation System
Tempus1800 Necto
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Clinical Chemistry

view channel
Image: The steps involved in the electric field-induced capture and release (EFIRM) assay (Photo courtesy of UCLA School of Dentistry)

Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation

Early detection of cancer and other serious diseases is crucial for effective treatment and improved outcomes, yet current diagnostic methods often involve invasive procedures and complex sample preparation.... Read more

Molecular Diagnostics

view channel
Image: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is FDA-cleared for use in diagnosing Alzheimer’s (Photo courtesy of Fujirebio)

First FDA Cleared Blood Test for Alzheimer’s Diagnosis Marks Turning Point in Early Detection

Alzheimer’s disease is a progressive form of dementia that affects memory, cognition, and behavior, eventually interfering with daily activities. Early and accurate diagnosis is essential to improving... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.